Cargando…
Promising development from translational or perhaps anti-translational research in breast cancer
BACKGROUND: A great deal of the public’s money has been spent on cancer research but demonstrable benefits to patients have not been proportionate. We are a group of scientists and physicians who several decades ago were confronted with bimodal relapse patterns among early stage breast cancer patien...
Autores principales: | Retsky, Michael, Demicheli, Romano, Hrushesky, William JM, Forget, Patrice, De Kock, Marc, Gukas, Isaac, Rogers, Rick A, Baum, Michael, Pachmann, Katharine, Vaidya, Jayant S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560986/ https://www.ncbi.nlm.nih.gov/pubmed/23369485 http://dx.doi.org/10.1186/2001-1326-1-17 |
Ejemplares similares
-
Reduction of Breast Cancer Relapses with Perioperative Non-Steroidal Anti-Inflammatory Drugs: New Findings and a Review
por: Retsky, Michael, et al.
Publicado: (2013) -
Surgery Triggers Outgrowth of Latent Distant Disease in Breast Cancer: An Inconvenient Truth?
por: Retsky, Michael, et al.
Publicado: (2010) -
Breast cancer and the black swan
por: Retsky, Michael, et al.
Publicado: (2020) -
Recent translational research: computational studies of breast cancer
por: Retsky, Michael, et al.
Publicado: (2005) -
Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer
por: Retsky, Michael W, et al.
Publicado: (2009)